Back to Journals » OncoTargets and Therapy » Volume 16

Original Research

Single-Center Retrospective Clinical Evaluation of Venetoclax Combined with HMAs and Half-Dose CAG for Unfit or Refractory/Relapsed AML

       
Total article views   HTML views PDF downloads Totals
2,942 Dovepress* 2,752+ 85 2,837
PubMed Central* 190 83 273
Totals 2,942 168 3,110
*Since 13 June 2023

View citations on PubMed Central and Google Scholar